Drug intelligence / Profile preview

sodium gualenate

Development stage
Unknown
Lead developer
Nippon Shinyaku
Modality
Small Molecules
Administration
Oral, Topical, Ophthalmic, Buccal
01

Overview

Sodium gualenate is a water-soluble, small molecule derivative of guaiazulene, a natural azulene compound found in chamomile oil. It is primarily utilized for its anti-inflammatory, cytoprotective, and wound-healing properties. The drug acts by protecting the gastric mucosa, inhibiting the release of histamine from mast cells, and suppressing the emigration of leukocytes to sites of inflammation. Clinically, sodium gualenate is indicated for the treatment of gastric and duodenal ulcers, gastritis, and various inflammatory conditions of the oral and pharyngeal cavities, including stomatitis, pharyngitis, and tonsillitis. It is also formulated for ophthalmic use in treating conjunctivitis and blepharitis, and is incorporated into cosmetic products for its skin-conditioning effects.

Brand names
Azunol
Other names
guaiazulene sulfonate sodiumsodium azulene sulfonate薁磺酸钠sodium 1,4-dimethyl-7-isopropylazulene-3-sulfonateguaiazulenesulfonate sodium

Beyond the preview

Go deeper on sodium gualenate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium gualenate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call